Krishan Gopal Thakur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Krishan Gopal Thakur has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
- Ramandeep Singh
Centre for Tuberculosis Research, Tuberculosis Research Laboratory, Translational Health Science and Technology Institute, Faridabad, India
8 shared publications Sahil Kumar
CSIR-Institute of Microbial Technology, Ministry of Science & Technology, Sector 39A Rd, 39A, Sector 39, 160036, Chandigarh, India
6 shared publications- Srajan Kapoor
Structural Biology Laboratory, G. N. Ramachandran Protein Centre, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India
6 shared publications - Balasubramanian Gopal
Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India
5 shared publications Dipesh Kumar Verma
Structural Biology Laboratory, G. N. Ramachandran Protein Centre, Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh, India
5 shared publicationsGundeep Kaur
Structural Biology Laboratory, G. N. Ramachandran Protein Centre, Council of Scientific and Industrial Research-Institute of Microbial Technology
5 shared publications
Latest Publications
- 23 September 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (6) , 11177-11202
Discovery of a new SARS-CoV-2 Mpro inhibitor from a natural product and natural product-like compound database using in silico and in vitro studies
This current study employs structure-guided virtual screening to identify potential inhibitors from 69,075 natural product or natural product-like compounds in the InterBioscreen (IBS) database against the SARS-CoV-2 Main protease (Mpro), a well-validated target. From high-throughput structure-guided virtual screening, subsequently followed by more rigorous re-docking, top seven compounds were chosen as hits based on their high binding affinity and specific H-bond interactions with the active-site residues of Mpro. All these compounds were new for this target as well as the virus. The stability of the seven protein-ligand complexes was further assessed using molecular dynamics (MD) simulations and the MM-GBSA method. The ADME/Tox profile of these seven compounds was also predicted theoretically. After MD simulation, only three compounds, viz. STOCK1N-86169, STOCK1N-88750, and STOCK1N-65657 were identified as high-potential candidates for Mpro inhibition. To confirm the in silico analysis results, an in vitro FRET-based Mpro inhibition assay and an ELISA-based SARS-CoV-2 inhibition assay were performed. From these in vitro investigations, STOCK1N-86169 was identified as the only potent Mpro inhibitor, exhibiting an IC50 of 3.8 µM. Independent confirmation of STOCK1N-86169 binding to Mpro was obtained by differential scanning calorimetry (DSC), which revealed an increase of approximately 15 °C in the melting temperature (Tm) of the Mpro–STOCK1N-86169 complex relative to the apo-protein. In the cytotoxicity assay, it showed CC50 > 100 µM for HeLa, ~ 100 µM for the Huh-7 cell line, and ~ 33.5 µM for the Vero E6 cell line. In the Vero cell-based SARS-CoV-2 infection assay, it showed an EC50 of ~ 7 µM, with a reasonable Selective Index (S.I.) of ~ 5-fold. Our study suggests that the natural product like compound STOCK1N-86169, which presents a new scaffold for Mpro inhibition and also SARS-CoV-2, may be a promising candidate for further development as an effective inhibitor of SARS-CoV-2 Mpro. Graphical abstract
- 23 September 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (6) , 11177-11202
Discovery of a new SARS-CoV-2 Mpro inhibitor from a natural product and natural product-like compound database using in silico and in vitro studies
This current study employs structure-guided virtual screening to identify potential inhibitors from 69,075 natural product or natural product-like compounds in the InterBioscreen (IBS) database against the SARS-CoV-2 Main protease (Mpro), a well-validated target. From high-throughput structure-guided virtual screening, subsequently followed by more rigorous re-docking, top seven compounds were chosen as hits based on their high binding affinity and specific H-bond interactions with the active-site residues of Mpro. All these compounds were new for this target as well as the virus. The stability of the seven protein-ligand complexes was further assessed using molecular dynamics (MD) simulations and the MM-GBSA method. The ADME/Tox profile of these seven compounds was also predicted theoretically. After MD simulation, only three compounds, viz. STOCK1N-86169, STOCK1N-88750, and STOCK1N-65657 were identified as high-potential candidates for Mpro inhibition. To confirm the in silico analysis results, an in vitro FRET-based Mpro inhibition assay and an ELISA-based SARS-CoV-2 inhibition assay were performed. From these in vitro investigations, STOCK1N-86169 was identified as the only potent Mpro inhibitor, exhibiting an IC50 of 3.8 µM. Independent confirmation of STOCK1N-86169 binding to Mpro was obtained by differential scanning calorimetry (DSC), which revealed an increase of approximately 15 °C in the melting temperature (Tm) of the Mpro–STOCK1N-86169 complex relative to the apo-protein. In the cytotoxicity assay, it showed CC50 > 100 µM for HeLa, ~ 100 µM for the Huh-7 cell line, and ~ 33.5 µM for the Vero E6 cell line. In the Vero cell-based SARS-CoV-2 infection assay, it showed an EC50 of ~ 7 µM, with a reasonable Selective Index (S.I.) of ~ 5-fold. Our study suggests that the natural product like compound STOCK1N-86169, which presents a new scaffold for Mpro inhibition and also SARS-CoV-2, may be a promising candidate for further development as an effective inhibitor of SARS-CoV-2 Mpro. Graphical abstract
- Open Access
- 8 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (11)
Structural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) encodes a huge repertoire of toxin–antitoxin (TA) systems, many of which remain uncharacterized. Here, we report the crystal structures of the VapC52 toxin and VapBC52 TA complex at a resolution of 2.6 and 3.2 Å, respectively. We show that VapC52 adopts a unique open dimeric conformation and inhibits mycobacterial growth by cleaving tRNA at the variable or anticodon loop region. Structure reveals that VapB52 adopts a distinct structural architecture and binds VapC52 with a 1:2 stoichiometry, respectively. Interestingly, binding of ssDNA activates VapB52 peptidase domain, resulting in auto-cleavage of VapB52 N-terminal domain which is critical for VapBC complex formation and neutralization. In addition to VapB52, co-expression of several other non-cognate VapB antitoxins abrogates the growth inhibition associated with VapC52 overexpression in Mycobacterium smegmatis (Msm) suggesting crosstalk among VapBC TA systems. Further, we demonstrate that the vapBC52 locus is dispensable for in vitro growth but essential for Mtb intracellular growth in macrophages and guinea pigs. Notably, VapC52 also cleaves mycobacteriophage D29 encoded tRNAs and confers resistance to phage infection in Msm. Taken together, we show that VapBC52 adopts a unique structural architecture, plays role in pathogenesis, and is possibly involved in mycobacterial antiphage defense mechanisms.
- 8 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (11)
Open AccessStructural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) encodes a huge repertoire of toxin–antitoxin (TA) systems, many of which remain uncharacterized. Here, we report the crystal structures of the VapC52 toxin and VapBC52 TA complex at a resolution of 2.6 and 3.2 Å, respectively. We show that VapC52 adopts a unique open dimeric conformation and inhibits mycobacterial growth by cleaving tRNA at the variable or anticodon loop region. Structure reveals that VapB52 adopts a distinct structural architecture and binds VapC52 with a 1:2 stoichiometry, respectively. Interestingly, binding of ssDNA activates VapB52 peptidase domain, resulting in auto-cleavage of VapB52 N-terminal domain which is critical for VapBC complex formation and neutralization. In addition to VapB52, co-expression of several other non-cognate VapB antitoxins abrogates the growth inhibition associated with VapC52 overexpression in Mycobacterium smegmatis (Msm) suggesting crosstalk among VapBC TA systems. Further, we demonstrate that the vapBC52 locus is dispensable for in vitro growth but essential for Mtb intracellular growth in macrophages and guinea pigs. Notably, VapC52 also cleaves mycobacteriophage D29 encoded tRNAs and confers resistance to phage infection in Msm. Taken together, we show that VapBC52 adopts a unique structural architecture, plays role in pathogenesis, and is possibly involved in mycobacterial antiphage defense mechanisms.
- 16 December 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 304, 118462
Targeted screening and rational optimization of bazedoxifene analogs as pan-variant SARS-CoV-2 entry inhibitors with improved pharmacokinetics
- 16 December 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 304, 118462
Targeted screening and rational optimization of bazedoxifene analogs as pan-variant SARS-CoV-2 entry inhibitors with improved pharmacokinetics
- Open Access
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
The yxiD gene from Bacillus subtilis 6633 encodes a polymorphic toxin with tRNase activity and is neutralized by the cognate immunity protein YxxD
Polymorphic toxin systems (PTS) are widespread and play an important role in bacterial competition and shaping communities. However, these systems are less studied in Gram-positive bacteria. Here, we structurally and functionally characterized YxiD-YxxD, a predicted member of PTS from Bacillus subtilis 6633. Using growth curve assays, we established that YxiD-YxxD codes for a toxin-immunity protein pair. We determined a 1.7 Å resolution crystal structure of the YxiDCTDH528A (C-terminal domain of YxiD) toxin bound to its cognate immunity protein YxxD. Structure revealed that the toxin adopts a Barnase/EndoU/colicin/RelE (BECR) fold, a characteristic of RNase toxins and the immunity protein sterically occludes binding of the molecular substrate to neutralize the toxin. Structural and other biophysical studies revealed that YxiDCTD-YxxD forms a stable 1:1 stoichiometric complex with KD of ∼9.4 nM. RNA Sequencing experiments revealed that expression of toxin results in downregulation of several tRNAs and essential genes involved in cell wall biosynthesis, resulting in cellular toxicity. We further demonstrate that YxiDCTD is a metal ion-dependent tRNase that cleaves several tRNAs. Taken together, our study provides the structural basis for YxiD neutralization by cognate immunity protein YxxD and establishes YxiDCTD toxin as a metal-dependent tRNase.
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
Open AccessThe yxiD gene from Bacillus subtilis 6633 encodes a polymorphic toxin with tRNase activity and is neutralized by the cognate immunity protein YxxD
Polymorphic toxin systems (PTS) are widespread and play an important role in bacterial competition and shaping communities. However, these systems are less studied in Gram-positive bacteria. Here, we structurally and functionally characterized YxiD-YxxD, a predicted member of PTS from Bacillus subtilis 6633. Using growth curve assays, we established that YxiD-YxxD codes for a toxin-immunity protein pair. We determined a 1.7 Å resolution crystal structure of the YxiDCTDH528A (C-terminal domain of YxiD) toxin bound to its cognate immunity protein YxxD. Structure revealed that the toxin adopts a Barnase/EndoU/colicin/RelE (BECR) fold, a characteristic of RNase toxins and the immunity protein sterically occludes binding of the molecular substrate to neutralize the toxin. Structural and other biophysical studies revealed that YxiDCTD-YxxD forms a stable 1:1 stoichiometric complex with KD of ∼9.4 nM. RNA Sequencing experiments revealed that expression of toxin results in downregulation of several tRNAs and essential genes involved in cell wall biosynthesis, resulting in cellular toxicity. We further demonstrate that YxiDCTD is a metal ion-dependent tRNase that cleaves several tRNAs. Taken together, our study provides the structural basis for YxiD neutralization by cognate immunity protein YxxD and establishes YxiDCTD toxin as a metal-dependent tRNase.
- Open Access
- 19 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10130
Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2
SARS-CoV-2 Spike - the sole neutralization target, is highly resilient to the immune pressure driving genetic evolution. While potency and breadth of neutralization are widely studied, the incomplete neutralization - the mechanism of resistance without needing genetic change - remains unexplored. Several monoclonal antibodies, although potent, showed incomplete neutralization of genetically homogeneous pseudovirus suggesting the existence of distinct spike conformations. The residual infectivity at high antibody concentration indicates a viral fraction with intrinsic resistance to the antibody. Although the published studies on spike glycosylation, structure, and conformations provide evidence of spike heterogeneity the precise mechanism for the incomplete neutralization has not been established. In this study, we devise a method to separate the un-neutralized virion population, called as persistent fraction of infectivity (PF), and characterize the viral spike protein. The neutralization resistance of PF is stable and unrelated to the conformational equilibrium that exists in the pseudovirus stock. The spike on the PF is highly cleaved between S1 and S2, adopts the closed conformation, and express more mannosidic glycans on RBD than the total virus population. Our study provides possible explanations for the incomplete neutralization by antibodies and delineates the association between furin cleavage of spike, its conformation and glycosylation.
- 19 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10130
Open AccessSpike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2
SARS-CoV-2 Spike - the sole neutralization target, is highly resilient to the immune pressure driving genetic evolution. While potency and breadth of neutralization are widely studied, the incomplete neutralization - the mechanism of resistance without needing genetic change - remains unexplored. Several monoclonal antibodies, although potent, showed incomplete neutralization of genetically homogeneous pseudovirus suggesting the existence of distinct spike conformations. The residual infectivity at high antibody concentration indicates a viral fraction with intrinsic resistance to the antibody. Although the published studies on spike glycosylation, structure, and conformations provide evidence of spike heterogeneity the precise mechanism for the incomplete neutralization has not been established. In this study, we devise a method to separate the un-neutralized virion population, called as persistent fraction of infectivity (PF), and characterize the viral spike protein. The neutralization resistance of PF is stable and unrelated to the conformational equilibrium that exists in the pseudovirus stock. The spike on the PF is highly cleaved between S1 and S2, adopts the closed conformation, and express more mannosidic glycans on RBD than the total virus population. Our study provides possible explanations for the incomplete neutralization by antibodies and delineates the association between furin cleavage of spike, its conformation and glycosylation.
- 7 September 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (3) , 3949-3975
9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease
Tilorone, a 9-fluorenone scaffold-based molecule, is a known broad-spectrum antiviral with an IC50 of 180 nM against SARS-CoV-2, but its mechanism is not known. In the present study, we found it to have weak activity against PLpro (IC50 = 30.7 ± 7.5 μM) and was inactive against Mpro. Several sulfonamide derivatives of 9-fluorenone, having the same scaffold as tilorone, were synthesized based on our in-silico studies to enhance their protease activity. They were evaluated for their inhibitory potential for targeting SARS-CoV-2 Mpro (main protease) and PLpro (papain-like protease) using FRET-based high-throughput screening and gel-based assays. Among the derivatives, 3e exhibited dual inhibition against Mpro (IC50 = 23 ± 3.4 μM) and PLpro (IC50 = 6.33 ± 0.5 μM), while 3h selectively inhibited PLpro (IC50= 5.94 ± 1.0 μM). Both 3e and 3h suppressed SARS-CoV-2 replication with IC50 values of 13.4 ± 0.28 μM and 18.2 ± 3.2 μM, respectively. Molecular docking and dynamics studies revealed that the NO2 group in 3h enhances the rigidity of the BL2 loop of PLpro, contributing to its higher PLpro activity. Both 3e and 3h showed antiviral activity comparable with standard alpha-ketoamide inhibitor (13b-K) in cell-based assays and were non-cytotoxic with acceptable selectivity indices (S.I. > 5.5). These findings suggest that 9-fluorenone-based sulfonamides, particularly 3e and 3h, may be promising candidates as dual or selective protease inhibitors against SARS-CoV-2. Graphical abstract 9-Fluorenone sulfonamides (3e, 3h) derived from tilorone inhibit SARS-CoV-2 proteases, suppress viral replication, and exhibit strong antiviral activity.
- 7 September 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (3) , 3949-3975
9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease
Tilorone, a 9-fluorenone scaffold-based molecule, is a known broad-spectrum antiviral with an IC50 of 180 nM against SARS-CoV-2, but its mechanism is not known. In the present study, we found it to have weak activity against PLpro (IC50 = 30.7 ± 7.5 μM) and was inactive against Mpro. Several sulfonamide derivatives of 9-fluorenone, having the same scaffold as tilorone, were synthesized based on our in-silico studies to enhance their protease activity. They were evaluated for their inhibitory potential for targeting SARS-CoV-2 Mpro (main protease) and PLpro (papain-like protease) using FRET-based high-throughput screening and gel-based assays. Among the derivatives, 3e exhibited dual inhibition against Mpro (IC50 = 23 ± 3.4 μM) and PLpro (IC50 = 6.33 ± 0.5 μM), while 3h selectively inhibited PLpro (IC50= 5.94 ± 1.0 μM). Both 3e and 3h suppressed SARS-CoV-2 replication with IC50 values of 13.4 ± 0.28 μM and 18.2 ± 3.2 μM, respectively. Molecular docking and dynamics studies revealed that the NO2 group in 3h enhances the rigidity of the BL2 loop of PLpro, contributing to its higher PLpro activity. Both 3e and 3h showed antiviral activity comparable with standard alpha-ketoamide inhibitor (13b-K) in cell-based assays and were non-cytotoxic with acceptable selectivity indices (S.I. > 5.5). These findings suggest that 9-fluorenone-based sulfonamides, particularly 3e and 3h, may be promising candidates as dual or selective protease inhibitors against SARS-CoV-2. Graphical abstract 9-Fluorenone sulfonamides (3e, 3h) derived from tilorone inhibit SARS-CoV-2 proteases, suppress viral replication, and exhibit strong antiviral activity.
- 22 August 2025
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 136 (9)
The role of amino acid composition in the antibacterial activity of laterosporulin analogs
Aim: This study aimed to compare the antimicrobial activity of the structural analogs of a class IId bacteriocin, laterosporulin. Methods and results: The antimicrobial peptide laterosporulin3 (LS3), produced by a Brevibacillus sp. strain SKR3, showed 96% identity to earlier described laterosporulin (LS) and 60% to laterosporulin10 (LS10) in amino acid composition. LS3 has a molecular weight of 5613 Da, the same as LS, yet differs in amino acid composition. Notable differences were found in their antimicrobial activity. Crystal structures of LS3 and LS10 were compared with LS. The analysis revealed that an additional Lys residue in LS3 enhances its net positive charge, leading to increased antimicrobial activity. FITC labeling showed the role of surface-displayed cationic Lys residues in the activity. Conclusion: Crystal structures of three different laterosporulins isolated from various strains of Brevibacillus were compared to understand the structure/function relationship. Results obtained in this study suggest that subtle variations in the amino acid composition of laterosporulins, distribution, and surface accessibility of charged residues can profoundly affect their antimicrobial activity.
- 22 August 2025
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 136 (9)
The role of amino acid composition in the antibacterial activity of laterosporulin analogs
Aim: This study aimed to compare the antimicrobial activity of the structural analogs of a class IId bacteriocin, laterosporulin. Methods and results: The antimicrobial peptide laterosporulin3 (LS3), produced by a Brevibacillus sp. strain SKR3, showed 96% identity to earlier described laterosporulin (LS) and 60% to laterosporulin10 (LS10) in amino acid composition. LS3 has a molecular weight of 5613 Da, the same as LS, yet differs in amino acid composition. Notable differences were found in their antimicrobial activity. Crystal structures of LS3 and LS10 were compared with LS. The analysis revealed that an additional Lys residue in LS3 enhances its net positive charge, leading to increased antimicrobial activity. FITC labeling showed the role of surface-displayed cationic Lys residues in the activity. Conclusion: Crystal structures of three different laterosporulins isolated from various strains of Brevibacillus were compared to understand the structure/function relationship. Results obtained in this study suggest that subtle variations in the amino acid composition of laterosporulins, distribution, and surface accessibility of charged residues can profoundly affect their antimicrobial activity.
- Open Access
- 10 March 2025
- Published by Springer Nature in Research Square
Conformational and glycan heterogeneity associated with furin cleavage of Spike as a cause of incomplete neutralization of SARS-CoV-2
SARS-CoV-2 Spike is the sole target of neutralizing antibodies (nAbs) but highly resilient to the immune pressure driving continuous genetic evolution. While potency and breadth of neutralization are widely studied, the incomplete neutralization - the mechanism of resistance without needing genetic change, remains unexplored. Several monoclonal antibodies, although potent, showed incomplete neutralization of genetically homogeneous pseudovirus suggesting the existence of distinct spike conformations peculiarly resistant to antibody binding. Incomplete neutralization is more commonly seen with NTD-specific antibodies typically exhibiting shallow neutralization curves in which neutralization saturates well below 100%. The residual infectivity in neutralization is thus accounted for the un-neutralized virions due to their intrinsic resistance to the tested antibody. Although the published studies on spike glycosylation, structure, and conformations provide insights on the spike heterogeneity the precise mechanism for the incomplete neutralization has not been established. In this study, we devised a method to separate the un-neutralized virion population, called as persistent fraction of infectivity (PF), and characterized its on-virus spike protein. The neutralization resistance of PF was stable and was unrelated to the conformational equilibrium that exists in the pseudovirus stock. The spike on the PF was highly cleaved between S1 and S2 subunits, adopted the closed conformation, and expressed more mannosidic glycans on RBD than the total virus population. Our study provides a precise explanation for the incomplete neutralization by the potent neutralizing antibodies and delineate the association between furin cleavage of spike and its conformation and glycosylation.
- 10 March 2025
- Published by Springer Nature in Research Square
Open AccessConformational and glycan heterogeneity associated with furin cleavage of Spike as a cause of incomplete neutralization of SARS-CoV-2
SARS-CoV-2 Spike is the sole target of neutralizing antibodies (nAbs) but highly resilient to the immune pressure driving continuous genetic evolution. While potency and breadth of neutralization are widely studied, the incomplete neutralization - the mechanism of resistance without needing genetic change, remains unexplored. Several monoclonal antibodies, although potent, showed incomplete neutralization of genetically homogeneous pseudovirus suggesting the existence of distinct spike conformations peculiarly resistant to antibody binding. Incomplete neutralization is more commonly seen with NTD-specific antibodies typically exhibiting shallow neutralization curves in which neutralization saturates well below 100%. The residual infectivity in neutralization is thus accounted for the un-neutralized virions due to their intrinsic resistance to the tested antibody. Although the published studies on spike glycosylation, structure, and conformations provide insights on the spike heterogeneity the precise mechanism for the incomplete neutralization has not been established. In this study, we devised a method to separate the un-neutralized virion population, called as persistent fraction of infectivity (PF), and characterized its on-virus spike protein. The neutralization resistance of PF was stable and was unrelated to the conformational equilibrium that exists in the pseudovirus stock. The spike on the PF was highly cleaved between S1 and S2 subunits, adopted the closed conformation, and expressed more mannosidic glycans on RBD than the total virus population. Our study provides a precise explanation for the incomplete neutralization by the potent neutralizing antibodies and delineate the association between furin cleavage of spike and its conformation and glycosylation.
- Open Access
- 27 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs
The genome of Mycobacterium tuberculosis encodes for a large repertoire of toxin-antitoxin systems. In the present study, MenT3 and MenT4 toxins belonging to MenAT subfamily of TA systems have been functionally characterized. We demonstrate that ectopic expression of these toxins inhibits bacterial growth and this is rescued upon co-expression of their cognate antitoxins. Here, we show that simultaneous deletion of menT3 and menT4 results in enhanced susceptibility of M. tuberculosis upon exposure to oxidative stress and attenuated growth in guinea pigs and mice. We observed reduced expression of transcripts encoding for proteins that are essential or required for intracellular growth in mid-log phase cultures of ΔmenT4ΔT3 compared to parental strain. Further, the transcript levels of proteins involved in efficient bacterial clearance were increased in lung tissues of ΔmenT4ΔT3 infected mice relative to parental strain infected mice. We show that immunization of mice and guinea pigs with ΔmenT4ΔT3 confers significant protection against M. tuberculosis infection. Remarkably, immunization of mice with ΔmenT4ΔT3 results in increased antigen-specific TH1 bias and activated memory T cell response. We conclude that MenT3 and MenT4 are important for M. tuberculosis pathogenicity and strains lacking menT3 and menT4 have the potential to be explored further as vaccine candidates.
- 27 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessMycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs
The genome of Mycobacterium tuberculosis encodes for a large repertoire of toxin-antitoxin systems. In the present study, MenT3 and MenT4 toxins belonging to MenAT subfamily of TA systems have been functionally characterized. We demonstrate that ectopic expression of these toxins inhibits bacterial growth and this is rescued upon co-expression of their cognate antitoxins. Here, we show that simultaneous deletion of menT3 and menT4 results in enhanced susceptibility of M. tuberculosis upon exposure to oxidative stress and attenuated growth in guinea pigs and mice. We observed reduced expression of transcripts encoding for proteins that are essential or required for intracellular growth in mid-log phase cultures of ΔmenT4ΔT3 compared to parental strain. Further, the transcript levels of proteins involved in efficient bacterial clearance were increased in lung tissues of ΔmenT4ΔT3 infected mice relative to parental strain infected mice. We show that immunization of mice and guinea pigs with ΔmenT4ΔT3 confers significant protection against M. tuberculosis infection. Remarkably, immunization of mice with ΔmenT4ΔT3 results in increased antigen-specific TH1 bias and activated memory T cell response. We conclude that MenT3 and MenT4 are important for M. tuberculosis pathogenicity and strains lacking menT3 and menT4 have the potential to be explored further as vaccine candidates.